• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Gen-NH-MCM-41@SA纳米颗粒的制备及其抗轮状病毒作用

The Preparation of Gen-NH-MCM-41@SA Nanoparticles and Their Anti-Rotavirus Effects.

作者信息

Song Lijun, Chen Jiabo, Feng Yuxuan, Zhou Yujing, Li Feng, Dai Guiqin, Yuan Yue, Yi Haosen, Qian Yupei, Yang Siyan, Chen Yang, Zhao Wenchang

机构信息

Guangdong Provincial Key Laboratory of Research and Development of Natural Drugs, School of Pharmacy, Guangdong Medical University, Dongguan 523808, China.

出版信息

Pharmaceutics. 2022 Jun 24;14(7):1337. doi: 10.3390/pharmaceutics14071337.

DOI:10.3390/pharmaceutics14071337
PMID:35890233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9318718/
Abstract

Genistein (Gen), a kind of natural isoflavone drug monomer with poor water solubility and low oral absorption, was incorporated into oral nanoparticles with a new mesoporous carrier material, NH-MCM-41, which was synthesized by copolycondensation. When the ratio of Gen to NH-MCM-41 was 1:0.5, the maximum adsorption capacity of Gen was 13.15%, the maximum drug loading was 12.65%, and the particle size of the whole core-shell structure was in the range of 370 nm-390 nm. The particles were characterized by a Malvern particle size scanning machine, XRD, Fourier transform infrared spectroscopy, scanning electron microscopy, and nitrogen adsorption and desorption. Finally, Gen-NH-MCM-41 was encapsulated by sodium alginate (SA), and the chimerism of this material, denoted as GEN-NH-MCM-41@SA, was investigated. In vitro release experiments showed that, after 5 h in artificial colon fluid (pH = 8.0), the cumulative release reached 99.56%. In addition, its anti-rotavirus (RV) effect showed that the maximum inhibition rate was 62.24% at a concentration of 30 μM in RV-infected Caco-2 cells, and it significantly reduced the diarrhea rate and diarrhea index in an RV-infected-neonatal mice model at a dose of 0.3 mg/g, which was better than the results of Gen. Ultimately, Gen-NH-MCM-41@SA was successfully prepared, which solves the problems of low solubility and poor absorption and provides an experimental basis for the application of Gen in the clinical treatment of RV infection.

摘要

染料木黄酮(Gen)是一种水溶性差、口服吸收低的天然异黄酮药物单体,通过共缩聚合成的新型介孔载体材料NH-MCM-41将其制成口服纳米颗粒。当Gen与NH-MCM-41的比例为1:0.5时,Gen的最大吸附量为13.15%,最大载药量为12.65%,整个核壳结构的粒径在370 nm - 390 nm范围内。通过马尔文粒度扫描仪、XRD、傅里叶变换红外光谱、扫描电子显微镜以及氮吸附-脱附对颗粒进行了表征。最后,用海藻酸钠(SA)对Gen-NH-MCM-41进行包封,并对这种材料(记为GEN-NH-MCM-41@SA)的嵌合情况进行了研究。体外释放实验表明,在人工结肠液(pH = 8.0)中5小时后,累积释放率达到99.56%。此外,其抗轮状病毒(RV)作用表明,在感染RV的Caco-2细胞中,浓度为30 μM时最大抑制率为62.24%,在感染RV的新生小鼠模型中,剂量为0.3 mg/g时显著降低了腹泻率和腹泻指数,效果优于Gen。最终,成功制备了Gen-NH-MCM-41@SA,解决了溶解度低和吸收差的问题,为Gen在RV感染临床治疗中的应用提供了实验依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/621abad73532/pharmaceutics-14-01337-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/209fe12011ac/pharmaceutics-14-01337-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/e13ff08905d4/pharmaceutics-14-01337-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/eb47c17e595f/pharmaceutics-14-01337-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/17f9d9657fff/pharmaceutics-14-01337-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/1d452559aa16/pharmaceutics-14-01337-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/4b12d8a6c05e/pharmaceutics-14-01337-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/6f0efca78fe0/pharmaceutics-14-01337-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/945070d5d958/pharmaceutics-14-01337-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/3c4a13d0ac18/pharmaceutics-14-01337-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/3900e7f05447/pharmaceutics-14-01337-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/1a85dabb7a71/pharmaceutics-14-01337-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/1f157a6a56d0/pharmaceutics-14-01337-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/6588dc4f50ef/pharmaceutics-14-01337-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/5eaa7301288a/pharmaceutics-14-01337-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/258e56e32509/pharmaceutics-14-01337-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/29ed1574b8f2/pharmaceutics-14-01337-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/5bf7a581004d/pharmaceutics-14-01337-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/89eac9598bf3/pharmaceutics-14-01337-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/186818d76687/pharmaceutics-14-01337-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/621abad73532/pharmaceutics-14-01337-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/209fe12011ac/pharmaceutics-14-01337-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/e13ff08905d4/pharmaceutics-14-01337-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/eb47c17e595f/pharmaceutics-14-01337-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/17f9d9657fff/pharmaceutics-14-01337-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/1d452559aa16/pharmaceutics-14-01337-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/4b12d8a6c05e/pharmaceutics-14-01337-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/6f0efca78fe0/pharmaceutics-14-01337-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/945070d5d958/pharmaceutics-14-01337-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/3c4a13d0ac18/pharmaceutics-14-01337-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/3900e7f05447/pharmaceutics-14-01337-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/1a85dabb7a71/pharmaceutics-14-01337-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/1f157a6a56d0/pharmaceutics-14-01337-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/6588dc4f50ef/pharmaceutics-14-01337-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/5eaa7301288a/pharmaceutics-14-01337-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/258e56e32509/pharmaceutics-14-01337-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/29ed1574b8f2/pharmaceutics-14-01337-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/5bf7a581004d/pharmaceutics-14-01337-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/89eac9598bf3/pharmaceutics-14-01337-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/186818d76687/pharmaceutics-14-01337-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60e2/9318718/621abad73532/pharmaceutics-14-01337-g020.jpg

相似文献

1
The Preparation of Gen-NH-MCM-41@SA Nanoparticles and Their Anti-Rotavirus Effects.Gen-NH-MCM-41@SA纳米颗粒的制备及其抗轮状病毒作用
Pharmaceutics. 2022 Jun 24;14(7):1337. doi: 10.3390/pharmaceutics14071337.
2
The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol.作为水不溶性西洛他唑的口服固体分散体载体的 MCM-48 型和 MCM-41 型介孔硅的研究。
Drug Dev Ind Pharm. 2014 Jun;40(6):819-28. doi: 10.3109/03639045.2013.788013. Epub 2013 Apr 17.
3
Preparation and controlled release of mesoporous MCM-41/propranolol hydrochloride composite drug.介孔 MCM-41/盐酸普萘洛尔复合材料的制备及控制释放。
J Microencapsul. 2013;30(2):173-80. doi: 10.3109/02652048.2012.714409. Epub 2012 Aug 15.
4
Adsorption and release of ampicillin antibiotic from ordered mesoporous silica.氨苄西林抗生素在有序介孔二氧化硅上的吸附与释放
J Colloid Interface Sci. 2017 Jul 1;497:217-225. doi: 10.1016/j.jcis.2017.03.021. Epub 2017 Mar 6.
5
Investigation of in vitro permeability and in vivo pharmacokinetic behavior of bare and functionalized MCM-41 and MCM-48 mesoporous silica nanoparticles: a burst and controlled drug release system for raloxifene.介孔硅 MCM-41 和 MCM-48 裸粒及功能化颗粒的体外渗透性能和体内药代动力学行为研究:雷洛昔芬的突释和控释给药系统。
Drug Dev Ind Pharm. 2019 Apr;45(4):587-602. doi: 10.1080/03639045.2019.1569028. Epub 2019 Feb 4.
6
Long-lasting anti-bacterial activity and bacteriostatic mechanism of tea tree oil adsorbed on the amino-functionalized mesoporous silica-coated by PAA.载有 PAA 的氨基功能化介孔硅吸附的茶树油的长效抗菌活性和抑菌机制。
Colloids Surf B Biointerfaces. 2020 Apr;188:110784. doi: 10.1016/j.colsurfb.2020.110784. Epub 2020 Jan 9.
7
Imidazolium-based ionic liquid functionalized mesoporous silica nanoparticles as a promising nano-carrier: response surface strategy to investigate and optimize loading and release process for Lapatinib delivery.基于咪唑鎓的离子液体功能化介孔硅纳米粒子作为一种有前途的纳米载体:响应面策略研究和优化拉帕替尼的载药和释放过程。
Pharm Dev Technol. 2020 Nov;25(9):1150-1161. doi: 10.1080/10837450.2020.1803909. Epub 2020 Aug 9.
8
Preparation, characterization, and pharmacokinetics study of a novel genistein-loaded mixed micelles system.新型染料木黄酮载药混合胶束系统的制备、表征及药代动力学研究。
Drug Dev Ind Pharm. 2018 Sep;44(9):1536-1542. doi: 10.1080/03639045.2018.1483384. Epub 2018 Jun 21.
9
Synthesis and Characterization of Chlorpyrifos/Copper(II) Schiff Base Mesoporous Silica with pH Sensitivity for Pesticide Sustained Release.对农药缓释具有pH敏感性的毒死蜱/铜(II)席夫碱介孔二氧化硅的合成与表征
J Agric Food Chem. 2016 Nov 2;64(43):8095-8102. doi: 10.1021/acs.jafc.6b03262. Epub 2016 Oct 21.
10
β-Lactoglobulin-Modified Mesoporous Silica Nanoparticles: A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostate Cancer Cells.β-乳球蛋白修饰的介孔二氧化硅纳米颗粒:一种将芬苯达唑靶向递送至前列腺癌细胞的有前景的载体。
Pharmaceutics. 2022 Apr 18;14(4):884. doi: 10.3390/pharmaceutics14040884.

本文引用的文献

1
Comparison of Structure and Adsorption Properties of Mesoporous Silica Functionalized with Aminopropyl Groups by the Co-Condensation and the Post Grafting Methods.共缩聚法和后接枝法制备的氨丙基官能化介孔二氧化硅的结构与吸附性能比较
Materials (Basel). 2021 Jan 29;14(3):628. doi: 10.3390/ma14030628.
2
FeO@mSiO core-shell nanocomposite capped with disulfide gatekeepers for enzyme-sensitive controlled release of anti-cancer drugs.由二硫键守门人封端的FeO@mSiO核壳纳米复合材料用于抗癌药物的酶敏感控释。
J Mater Chem B. 2015 Feb 14;3(6):1010-1019. doi: 10.1039/c4tb01788a. Epub 2014 Dec 8.
3
Omega-3PUFA Attenuates MNU-Induced Colorectal Cancer in Rats by Blocking PI3K/AKT/Bcl-2 Signaling.
ω-3多不饱和脂肪酸通过阻断PI3K/AKT/Bcl-2信号通路减轻N-甲基-N-亚硝基脲诱导的大鼠结直肠癌
Onco Targets Ther. 2020 Mar 5;13:1953-1965. doi: 10.2147/OTT.S241298. eCollection 2020.
4
Genistein improves viability, proliferation and mitochondrial function of cardiomyoblasts cultured in physiologic and peroxidative conditions.染料木黄酮可提高生理和过氧化条件下培养的心肌细胞活力、增殖和线粒体功能。
Int J Mol Med. 2019 Dec;44(6):2298-2310. doi: 10.3892/ijmm.2019.4365. Epub 2019 Oct 3.
5
Equol: A Bacterial Metabolite from The Daidzein Isoflavone and Its Presumed Beneficial Health Effects.大豆苷元:来自大豆异黄酮的细菌代谢产物及其推测的有益健康作用。
Nutrients. 2019 Sep 16;11(9):2231. doi: 10.3390/nu11092231.
6
Vascular Endothelial Cell Biology: An Update.血管内皮细胞生物学:最新进展。
Int J Mol Sci. 2019 Sep 7;20(18):4411. doi: 10.3390/ijms20184411.
7
Gastric Cancer Stem Cells: Mechanisms and Therapeutic Approaches.胃癌干细胞:机制与治疗方法
Yonsei Med J. 2018 Dec;59(10):1150-1158. doi: 10.3349/ymj.2018.59.10.1150.
8
Peroxisome Proliferator-Activated Receptor and PGC-1 in Cancer: Dual Actions as Tumor Promoter and Suppressor.过氧化物酶体增殖物激活受体与PGC-1在癌症中的作用:兼具肿瘤促进因子和抑制因子的双重作用
PPAR Res. 2018 Jan 21;2018:6727421. doi: 10.1155/2018/6727421. eCollection 2018.
9
Ecballium Elaterium for Gastrointestinal Cancer.喷瓜用于治疗胃肠道癌。
Asian Pac J Cancer Prev. 2018 Mar 27;19(3):583-583. doi: 10.22034/APJCP.2018.19.3.583.
10
The influence of peroxisome proliferator-activated receptor γ (PPARγ) ligands on cancer cell tumorigenicity.过氧化物酶体增殖物激活受体γ(PPARγ)配体对癌细胞致瘤性的影响。
Gene. 2018 Apr 5;649:14-22. doi: 10.1016/j.gene.2018.01.018. Epub 2018 Jan 31.